売上高・売上総利益率の推移
| 年度 |
売上高 |
売上総利益率 |
| 2023/12 |
126,325 |
- |
| 2022/12 |
7,128 |
- |
| 2021/12 |
144,927 |
- |
| 2020/12 |
33,215 |
- |
| 2019/12 |
34,505 |
- |
| 2018/12 |
28,267 |
- |
| 2017/12 |
32,100 |
- |
| 2016/12 |
21,766 |
- |
| 2015/12 |
0 |
- |
営業利益・営業利益率の推移
| 年度 |
営業利益 |
営業利益率 |
| 2024/12 |
-121,315 |
- |
| 2023/12 |
-107,983 |
-85.5% |
| 2022/12 |
-246,490 |
-3458.1% |
| 2021/12 |
-64,493 |
-44.5% |
| 2020/12 |
-88,130 |
-265.3% |
| 2019/12 |
-71,876 |
-208.3% |
| 2018/12 |
-100,284 |
-354.8% |
| 2017/12 |
-91,395 |
-284.7% |
| 2016/12 |
-92,839 |
-426.5% |
| 2015/12 |
-54,856 |
- |
|
（単位：千ドル）
|
2015/12
|
2016/12
|
2017/12
|
2018/12
|
2019/12
|
2020/12
|
2021/12
|
2022/12
|
2023/12
|
2024/12
|
|
売上高
|
0
|
21,766
|
32,100
|
28,267
|
34,505
|
33,215
|
144,927
|
7,128
|
126,325
|
-
|
|
売上成長率（％）
|
-
|
-
|
|
|
|
-3.7
|
336.3
|
-95.1
|
1672.2
|
-
|
|
研究開発費
|
38,095
|
81,989
|
89,455
|
95,955
|
80,141
|
90,570
|
141,891
|
172,920
|
145,860
|
64,600
|
|
営業費用
|
54,856
|
114,605
|
123,495
|
128,551
|
106,381
|
121,345
|
209,420
|
253,618
|
234,308
|
121,315
|
|
営業利益
|
-54,856
|
-92,839
|
-91,395
|
-100,284
|
-71,876
|
-88,130
|
-64,493
|
-246,490
|
-107,983
|
-121,315
|
|
営業利益率 (%)
|
-
|
|
|
|
|
-265.3
|
-44.5
|
-3458.1
|
-85.5
|
-
|
|
純利益
|
-54,780
|
-91,579
|
-89,380
|
-98,942
|
-70,279
|
-89,127
|
-65,578
|
-250,157
|
-113,724
|
136
|
|
純利益率（％）
|
-
|
|
|
|
|
-268.3
|
-45.2
|
-3509.5
|
-90.0
|
-
|
|
一株あたり利益
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-2.31
|
-0.89
|
0
|
|
希薄化後一株あたり利益
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-2.31
|
-0.89
|
0
|
|
EBITDA
|
|
|
|
|
|
-81,552
|
-58,546
|
-239,861
|
-101,740
|
-115,847
|
|
EBITDAマージン（％）
|
-
|
|
|
|
|
-245.5
|
-40.4
|
-3365.1
|
-80.5
|
-
|